NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.25 AUD | +2.17% |
|
+5.19% | -18.90% |
| Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
| Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Evolution of the average Target Price on Neuren Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
63c143133e.adGOsFVQPWlyzS91vV1GXkurbVW7eXrQfNE16FGvsRQ.Mb-81DplVl8xgEQ-3wJyMAiZOgHPPhyJK-N2v3zu22MTue_9EyhuUEu5WA~c49e69e620e0e3d8733d42e87f26dddd
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
19.82
AUD
Average target price
26.74
AUD
Spread / Average Target
+34.89%
High Price Target
31
AUD
Spread / Highest target
+56.41%
Low Price Target
22.8
AUD
Spread / Lowest Target
+15.04%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- NEU Stock
- Consensus Neuren Pharmaceuticals Limited